RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

Completed · Not applicable

Conditions studied: Coronary Artery Disease

In brief

To observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population. To collect data on the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in bifurcated lesions.

Key facts

Study ID
NCT03584464
Run by
Medtronic Vascular
People needed
205
Starts
2018-05-14
Expected to finish
2022-09-28
Last updated by the study team
2023-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.